Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIPPS trial of dalteparin prophylaxis in thrombophilic pregnant women
ACTRN12608000446369Phase 4Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2000
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial of dalteparin in venous thromboembolism (VTE), preeclampsia, intrauterine growth restriction (IUGR) and 1 more (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoints: Severe or early-onset preeclampsia, Venous thromboembolic events and 1 more. Started Jul 2000; status: recruiting.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)preeclampsiaintrauterine growth restriction (IUGR)stillbirth
Beyond the preview
Go deeper on ACTRN12608000446369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000446369.